A
Ably Medical
Revolutionizing the very base of patient recovery
About Ably Medical
Ably Medical, founded in Ålesund, Norway, in late 2015, is a medical technology company focused on addressing the mounting pressures within the healthcare sector, such as nurse shortages and increasing patient numbers. The company was established by Kjell-Are Furnes, Arve Voldsund, Jørn Refsnæs, and Cato Bjørkli. Initially, the company's goal was to revolutionize the traditional hospital bed. However, a breakthrough in 2020 with their no-touch monitoring technology led to a strategic pivot, resulting in the development of their first product, LYNG.
The core of Ably Medical's offering is the LYNG system, a non-intrusive patient monitoring solution. This system utilizes a sensor mat placed under the bed mattress to continuously measure vital signs including heart rate, respiration rate, and movement without any direct patient contact. LYNG also functions as a connectivity hub, integrating with third-party devices to provide a comprehensive view of other vitals like temperature, blood pressure, and blood oxygen levels. This B2B solution serves hospitals, nursing homes, and home care environments. The business model aims to reduce the workload for nursing staff by automating routine monitoring and documentation, which in turn helps to prevent adverse events like patient falls and pressure ulcers. By providing real-time data and alerts, LYNG enables early intervention, improves operational efficiency, and supports new care models like hospital-at-home services.
The company's journey has been marked by significant milestones, including a 2018 funding round that raised $4 million from Norwegian angel investors. Another funding round was completed in 2021 with participation from investors like Ronja Capital, Kongsberg Innovation, and the Italian hospital furniture supplier, Malvestio. Ably Medical has actively collaborated with hospitals in Norway, Germany, and Canada to co-create its technologies. The company is pursuing Class I certification for LYNG in 2024, with plans for a commercial launch the same year, and aims for a more advanced Class IIb certification between 2025 and 2026.
Source: Dealroom company dataNews
Open roles
Ably Medical in the Oslo ecosystem
The Ably Medical office with the hot startups, most funded companies and investors around it. Hover or tap a pin.
Dealroom maps whole ecosystems like this one for cities, regions and governments. See the ecosystem platform →
Investors
From Dealroom's funding and investor records, grouped by the round each investor first entered.
Seed1 investor entered at this stage
Innovation Norway
Series A2 investors entered at this stage
- RCRonja Capital
- JHJakob Hatteland
Source: Dealroom Talent Intelligence.
Global footprint
team presence
Market sentiment
An AI-synthesised read of the highest-engagement posts about Ably Medical on X, ranked by likes and reposts, corporate channels excluded.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See Ably Medical on the full Dealroom platform
Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.
